Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Itoh

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Current Research in Translational Medicine|November 29, 2022
Multiomics and artificial intelligence enabled peripheral blood-based prediction of amnestic mild cognitive impairmentYota Tatara, Hiromi Yamazaki, Fumiki Katsuoka, et al.
Cancer Science|May 7, 2022
Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseasesHiromichi Iwamura, Kei Mizuno, Shusuke Akamatsu, et al.
Scientific Reports|July 17, 2024
Novel insight into nicotinamide adenine dinucleotide and related metabolites in cancer patients undergoing surgeryHiroaki Fujita, Taiichi Wakiya, Yota Tatara, et al.
Blood|January 8, 2025
Selenoprotein-mediated redox regulation shapes the cell fate of HSCs and mature lineagesYumi Aoyama, Hiromi Yamazaki, Koutarou Nishimura, et al.
Oncotarget|October 21, 2016
The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugsPei Y Liu, Nicholas Sokolowski, Su T Guo, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Current Research in Translational Medicine|November 29, 2022
Multiomics and artificial intelligence enabled peripheral blood-based prediction of amnestic mild cognitive impairmentYota Tatara, Hiromi Yamazaki, Fumiki Katsuoka, et al.
Cancer Science|May 7, 2022
Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseasesHiromichi Iwamura, Kei Mizuno, Shusuke Akamatsu, et al.
Scientific Reports|July 17, 2024
Novel insight into nicotinamide adenine dinucleotide and related metabolites in cancer patients undergoing surgeryHiroaki Fujita, Taiichi Wakiya, Yota Tatara, et al.
Blood|January 8, 2025
Selenoprotein-mediated redox regulation shapes the cell fate of HSCs and mature lineagesYumi Aoyama, Hiromi Yamazaki, Koutarou Nishimura, et al.
Oncotarget|October 21, 2016
The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugsPei Y Liu, Nicholas Sokolowski, Su T Guo, et al.
Pageof 18